Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568490 · ClinicalTrials.gov registry record
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
A clinical trial of Lung Cancer and Head and Neck Cancer, sponsored by Stanford University.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT00568490: Recruiting study of Lung Cancer and Head and Neck Cancer, sponsored by Stanford University.
NCT00568490 is a study of Lung Cancer and Head and Neck Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 200 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00568490, a study of Lung Cancer and Head and Neck Cancer, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify and confirm new blood and tissue markers for prognosis and tumor hypoxia. Tumor hypoxia, or the condition of low oxygen in the tumor, has been shown to increase the risk of tumor spread and enhance tumor resistance to the standard treatment of radiation and chemotherapy in head and neck and lung cancers. We have recently identified several proteins or markers in the blood and in tumors (including osteopontin, lysyl oxidase, macrophage inhibiting factor and proteomic technology) in the laboratory that may be able to identify tumors with low oxygen levels or more aggressive behaving tumors.
Conditions Studied
Interventions
- PROCEDURE Phlebotomy
- PROCEDURE Tumor biopsy
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 1998-09-01 |
| Est. Completion | 2026-04-30 |
What NCT00568490 shows while recruiting
NCT00568490 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (79% lower).
The record links to 5 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Phlebotomy is the first listed.
NCT00568490 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00568490 about?
NCT00568490 is a clinical study titled "Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers". The purpose of this study is to identify and confirm new blood and tissue markers for prognosis and tumor hypoxia. Tumor hypoxia, or the condition of low oxygen in the tumor, has been shown to increase the risk of tumor spread and enhance tumor resistance to the standard treatment of radiation and c...
What is the current status of trial NCT00568490?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 1998-09-01. Estimated completion is 2026-04-30.
What conditions does trial NCT00568490 study?
This clinical trial studies the following conditions: Lung Cancer, Head and Neck Cancer, Head and Neck Cancers, Lip Cancer, Lip Neoplasms.
What interventions are being tested in trial NCT00568490?
The interventions under investigation include: Phlebotomy (PROCEDURE), Tumor biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00568490?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00568490 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00568490's enrollment target sits among peer trials
200 130th of 409 higher than 277 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI